Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

451 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic Role of Diffusion-weighted MR Imaging for Resectable Gastric Cancer.
Giganti F, Orsenigo E, Esposito A, Chiari D, Salerno A, Ambrosi A, Albarello L, Mazza E, Staudacher C, Del Maschio A, De Cobelli F. Giganti F, et al. Among authors: mazza e. Radiology. 2015 Aug;276(2):444-52. doi: 10.1148/radiol.15141900. Epub 2015 Mar 27. Radiology. 2015. PMID: 25816106
Apparent diffusion coefficient modifications in assessing gastro-oesophageal cancer response to neoadjuvant treatment: comparison with tumour regression grade at histology.
De Cobelli F, Giganti F, Orsenigo E, Cellina M, Esposito A, Agostini G, Albarello L, Mazza E, Ambrosi A, Socci C, Staudacher C, Del Maschio A. De Cobelli F, et al. Among authors: mazza e. Eur Radiol. 2013 Aug;23(8):2165-74. doi: 10.1007/s00330-013-2807-0. Epub 2013 Apr 16. Eur Radiol. 2013. PMID: 23588582
Response to chemotherapy in gastric adenocarcinoma with diffusion-weighted MRI and (18) F-FDG-PET/CT: correlation of apparent diffusion coefficient and partial volume corrected standardized uptake value with histological tumor regression grade.
Giganti F, De Cobelli F, Canevari C, Orsenigo E, Gallivanone F, Esposito A, Castiglioni I, Ambrosi A, Albarello L, Mazza E, Gianolli L, Staudacher C, Del Maschio A. Giganti F, et al. Among authors: mazza e. J Magn Reson Imaging. 2014 Nov;40(5):1147-57. doi: 10.1002/jmri.24464. Epub 2013 Nov 8. J Magn Reson Imaging. 2014. PMID: 24214734
Prospective comparison of MR with diffusion-weighted imaging, endoscopic ultrasound, MDCT and positron emission tomography-CT in the pre-operative staging of oesophageal cancer: results from a pilot study.
Giganti F, Ambrosi A, Petrone MC, Canevari C, Chiari D, Salerno A, Arcidiacono PG, Nicoletti R, Albarello L, Mazza E, Gallivanone F, Gianolli L, Orsenigo E, Esposito A, Staudacher C, Del Maschio A, De Cobelli F. Giganti F, et al. Among authors: mazza e. Br J Radiol. 2016 Dec;89(1068):20160087. doi: 10.1259/bjr.20160087. Epub 2016 Oct 21. Br J Radiol. 2016. PMID: 27767330 Free PMC article.
Pre-treatment MDCT-based texture analysis for therapy response prediction in gastric cancer: Comparison with tumour regression grade at final histology.
Giganti F, Marra P, Ambrosi A, Salerno A, Antunes S, Chiari D, Orsenigo E, Esposito A, Mazza E, Albarello L, Nicoletti R, Staudacher C, Del Maschio A, De Cobelli F. Giganti F, et al. Among authors: mazza e. Eur J Radiol. 2017 May;90:129-137. doi: 10.1016/j.ejrad.2017.02.043. Epub 2017 Mar 1. Eur J Radiol. 2017. PMID: 28583623
Effect of neoadjuvant chemotherapy on HER-2 expression in surgically treated gastric and oesophagogastric junction carcinoma: a multicentre Italian study.
Chiari D, Orsenigo E, Guarneri G, Baiocchi GL, Mazza E, Albarello L, Bissolati M, Molfino S, Staudacher C; Gruppo Italiano Ricerca Cancro Gastrico (GIRCG). Chiari D, et al. Among authors: mazza e. Updates Surg. 2017 Mar;69(1):35-43. doi: 10.1007/s13304-017-0423-2. Epub 2017 Mar 8. Updates Surg. 2017. PMID: 28276033
PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) regimen as second-line therapy in patients with progressive or recurrent pancreatic cancer after gemcitabine-containing chemotherapy.
Reni M, Cereda S, Mazza E, Passoni P, Nicoletti R, Balzano G, Zerbi A, Arcidiacono PG, Staudacher C, Di Carlo V. Reni M, et al. Among authors: mazza e. Am J Clin Oncol. 2008 Apr;31(2):145-50. doi: 10.1097/COC.0b013e31814688f7. Am J Clin Oncol. 2008. PMID: 18391598 Clinical Trial.
451 results